Buprenorphine in New Zealand 2007 Strategic Assessment

Published online: 
16 November 2007
Buprenorphine in New Zealand 2007 Strategic Assessment cover.

Buprenorphine is a strong synthetic opioid analgesic. It has properties similar to opium and therefore morphine salts.

This report looks at its risks and the sugestion  that buprenorphine be reclassified from a Class C to Class B controlled drug. It is thought that a Class B status would provide greater control over its use and provide for monitoring capabilities over its distribution and use.

Publishing information

  • Date of publication:
    16 November 2007
  • Citation:
    NEW ZEALAND NATIONAL DRUG INTELLIGENCE BUREAU JOINT OPERATION OF POLICE, CUSTOMS & HEALTH DEPARTMENTS
  • Ordering information:
    Only soft copy available to download
Back to top